Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Panagiotis Petrou. (2021) The tyranny of the SW quadrant. Journal of Medical Economics 24:1, pages 741-742.
Read now
Read now
Articles from other publishers (23)
Max Kindred, Zahratu Shabrina & Neily Zakiyah. (2023) Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom. Applied Health Economics and Health Policy.
Crossref
Crossref
Suzana Bojic, Nebojsa Ladjevic, Ivan Palibrk, Ivan Soldatovic, Ivana Likic-Ladjevic, Winfried Meissner, Ruth Zaslansky, Ulrike M Stamer, Philipp Baumbach & Dusica Stamenkovic. (2023) Cost-effectiveness of the Perioperative Pain Management Bundle a registry-based study. Frontiers in Public Health 11.
Crossref
Crossref
Lidia Engel, Mario Alvarez-Jimenez, Daniela Cagliarini, Simon D’Alfonso, Jan Faller, Lee Valentine, Peter Koval, Sarah Bendall, Shaunagh O’Sullivan, Simon Rice, Chris Miles, David L Penn, Jess Phillips, Penni Russon, Reeva Lederman, Eoin Killackey, Shalini Lal, Sue Maree Cotton, Cesar Gonzalez-Blanch, Helen Herrman, Patrick D McGorry, John F M Gleeson & Cathrine Mihalopoulos. (2023) The Cost-Effectiveness of a Novel Online Social Therapy to Maintain Treatment Effects From First-Episode Psychosis Services: Results From the Horyzons Randomized Controlled Trial. Schizophrenia Bulletin.
Crossref
Crossref
Aurélie Duruflé, Claire Le Meur, Patrice Piette, Bastien Fraudet, Emilie Leblong & Philippe Gallien. (2023) Cost effectiveness of a telerehabilitation intervention vs home based care for adults with severe neurologic disability: A randomized clinical trial. DIGITAL HEALTH 9.
Crossref
Crossref
Gianluca De Rubeis, Sebastiano Fabiano, Luca Bertaccini, Andrea Wlderk, Francesca Romana Pezzella, Sabrina Anticoli, Luca Saba, Claudio Gasperini & Enrico Pampana. (2023) Is Mechanical Thrombectomy or Thrombolysis Universally Cost-Effective? A Systematic Review of the Literature. World Neurosurgery 169, pages e29-e39.
Crossref
Crossref
Juliette de Vos, Laurenske A. Visser, Aletta A. de Beer, Mattia Fornasa, Patrick J. Thoral, Paul W.G. Elbers & Giovanni Cinà. (2022) The Potential Cost-Effectiveness of a Machine Learning Tool That Can Prevent Untimely Intensive Care Unit Discharge. Value in Health 25:3, pages 359-367.
Crossref
Crossref
Frank Sandmann, Mary Ramsay, W. John Edmunds, Yoon H. Choi & Mark Jit. (2021) How to Prevent Vaccines Falling Victim to Their Own Success: Intertemporal Dependency of Incidence Levels on Indirect Effects in Economic Reevaluations. Value in Health 24:10, pages 1391-1399.
Crossref
Crossref
Frank Sandmann, Mark Jit, Nick Andrews, Hannah L. Buckley, Helen Campbell, Sonia Ribeiro, Bersabeh Sile, Julia Stowe, Elise Tessier, Mary Ramsay, Gayatri Amirthalingam & Yoon H. Choi. (2021) Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis. Vaccine 39:32, pages 4500-4509.
Crossref
Crossref
Nilay Hepgul, Rebecca Wilson, Deokhee Yi, Catherine Evans, Sabrina Bajwah, Vincent Crosby, Andrew Wilcock, Fiona Lindsay, Anthony Byrne, Carolyn Young, Karen Groves, Clare Smith, Rachel Burman, K Ray Chaudhuri, Eli Silber, Irene J Higginson & Wei Gao. (2020) Immediate versus delayed short-term integrated palliative care for advanced long-term neurological conditions: the OPTCARE Neuro RCT. Health Services and Delivery Research 8:36, pages 1-80.
Crossref
Crossref
Nkuba Nyerere, Livingstone S. Luboobi, Saul C. Mpeshe & Gabriel M. Shirima. (2020) Optimal Control Strategies for the Infectiology of Brucellosis. International Journal of Mathematics and Mathematical Sciences 2020, pages 1-17.
Crossref
Crossref
Adriënne H. Rotteveel, Mattijs S. Lambooij, Nicolaas P. A. Zuithoff, Job van Exel, Karel G. M. Moons & G. Ardine de Wit. (2020) Valuing Healthcare Goods and Services: A Systematic Review and Meta-Analysis on the WTA-WTP Disparity. PharmacoEconomics 38:5, pages 443-458.
Crossref
Crossref
Nadège Costa, Michael Mounié, Geraldine Bernard, Laurent Bieler, Laurent Molinier, Elie Serrano & Guillaume de Bonnecaze. (2019) Cost‐effectiveness of trans‐nasal endoscopic sphenopalatine artery ligation vs arterial embolisation for intractable epistaxis: Long‐term analyses. Clinical Otolaryngology 44:4, pages 511-517.
Crossref
Crossref
Xuanqian Xie, Lindsey Falk, James M. Brophy, Hong Anh Tu, Jennifer Guo, Olga Gajic-Veljanoski, Nancy Sikich, Irfan A. Dhalla & Vivian Ng. (2019) A Non-inferiority Framework for Cost-Effectiveness Analysis. International Journal of Technology Assessment in Health Care 35:4, pages 291-297.
Crossref
Crossref
Brian Custer. 2019. Blood Safety. Blood Safety
53
81
.
Petr Winkler, Leonardo Koeser, Lucie Kondrátová, Hana Marie Broulíková, Marek Páv, Lucie Kališová, Barbara Barrett & Paul McCrone. (2018) Cost-effectiveness of care for people with psychosis in the community and psychiatric hospitals in the Czech Republic: an economic analysis. The Lancet Psychiatry 5:12, pages 1023-1031.
Crossref
Crossref
Vincent Bremer, Dennis Becker, Spyros Kolovos, Burkhardt Funk, Ward van Breda, Mark Hoogendoorn & Heleen Riper. (2018) Predicting Therapy Success and Costs for Personalized Treatment Recommendations Using Baseline Characteristics: Data-Driven Analysis. Journal of Medical Internet Research 20:8, pages e10275.
Crossref
Crossref
Sumit ThakarNiranjana RajagopalSubramaniyan Mani, Maya Shyam, Saritha AryanArun S. RaoRakshith SrinivasaDilip MohanAlangar S. Hegde. (2018) Comparison of telemedicine with in-person care for follow-up after elective neurosurgery: results of a cost-effectiveness analysis of 1200 patients using patient-perceived utility scores. Neurosurgical Focus 44:5, pages E17.
Crossref
Crossref
Aaron Y Lee, Thomas Butt, Emily Chew, Elvira Agron, Traci E Clemons, Catherine A Egan, Cecilia S Lee & Adnan Tufail. (2018) Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data. British Journal of Ophthalmology 102:4, pages 465-472.
Crossref
Crossref
Denise M. BoudreauGregory F. GuzauskasEr ChenDeepa LallaDarren TayamaSusan C. FaganDavid L. Veenstra. (2014) Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke. Stroke 45:10, pages 3032-3039.
Crossref
Crossref
Maarten Postma & Cornelis Boersma. 2014. Handboek farmaceutische geneeskunde. Handboek farmaceutische geneeskunde
99
118
.
Kate C. YoungCurtis G. BeneschBabak S. Jahromi. (2010) Cost-effectiveness of multimodal CT for evaluating acute stroke. Neurology 75:19, pages 1678-1685.
Crossref
Crossref
Christina M. van der Feltz-Cornelis. 2010. Ethics in Psychiatry. Ethics in Psychiatry
33
54
.
Rogier M. Klok, Nicolaas L.A. Arents, Robin de Vries, Jacob C. Thijs, Jacobus R.B.J. Brouwers, Jan H. Kleibeuker & Maarten J. Postma. (2005) Economic evaluation of a randomized trial comparinghelicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting. Clinical Therapeutics 27:10, pages 1647-1657.
Crossref
Crossref